Project description:Metagenomic next-generation sequence data of Suspected Infected Pancreatic Necrosis patients
| PRJNA771396 | ENA
Project description:Clinical Application and Evaluation of Metagenomic Next-Generation Sequencing in Patients with Suspected Sepsis: A Prospective Study
| PRJNA993449 | ENA
Project description:Clinical performance and impact of Probe-capture next-generation sequencing for sepsis diagnosis and therapeutic adjustment
Project description:NG-Capture-C profiling of chromatin interactions (using DpnII 3C and Oligo nucleotide sequence capture followed by Next generation sequencing) of enhancers, promoters and CTCF/Rad21 binding sites throughout a ~600kb region of the mouse Pax6 locus in β-TC3 cells treated with alpha amanitin. β-TC3 cell are a mouse pancreatic β cell derived from mouse insulinoma.
Project description:NG-Capture-C profiling of chromatin interactions (using DpnII 3C and Oligo nucleotide sequence capture followed by Next generation sequencing) of enhancers, promoters and CTCF/Rad21 binding sites throughout a ~600kb region of the mouse Pax6 locus in β-TC3 cells treated with alpha amanitin. β-TC3 cell are a mouse pancreatic β cell derived from mouse insulinoma.
2023-06-21 | GSE235334 | GEO
Project description:Clinical Evaluation of the ONETest, a Target-Capture Next-Generation Sequencing Platform, to Identify Respiratory Viruses
| PRJNA949626 | ENA
Project description:Clinical evaluation of metagenomic next-generation sequencing method for the diagnosis of suspected ascitic infection in patients with liver cirrhosis in a clinical laboratory
| PRJNA913604 | ENA
Project description:Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing.
| PRJNA606159 | ENA
Project description:Probe capture-based targeted next generation sequencing (tNGS) for microbial detection of dacryocystitis
Project description:Our data demonstrate the suitability of target capture technology for purifying very low quantities of Leptospira DNA from biological samples where the human genome is in vast excess. This enables deep sequencing of partial Leptospira genomes directly from clinical samples using next generation technologies and genotyping.
